Nicox enters agreement to acquire Aciex Therapeutics for up to $120 million

Nicox has signed an agreement to acquire outstanding equity in Aciex Therapeutics, a private U.S.-based ophthalmic pharmaceutical company.The agreement includes a $65 million upfront payment in newly issued Nicox shares and contingent value rights to shares that may increase the purchase total to a maximum of $120 million, according to a news release from Nicox. Completion of the agreement is subject to the approval of Nicox shareholders and other conditions.

Full Story →